The scientific advances in blood-based markers that allow for “precision medicine” to aid physicians and their teams to determine risk for multiple conditions, including heart disease and dementia, are exciting yet also lead to important considerations regarding consent and disclosure of results. Important information must be shared with patients, and families, and information on the AGREEDementia site ( The group helps guide when and how to tell people to access this risk information so that people understand it and get the information they want.

Please access the tools through the link below

More questions?
Feel free to reach out to [email protected] Co-Chair for the AGREEDementia Workgroup or [email protected]